Femasys Inc. (FEMY)
NCM – Real Time Price. Currency in USD
2.32
-0.03 (-1.28%)
Market open: Aug 12, 2026, 12:30 PM EDT
2.18
-0.17 (-7.23%)
Previous after-hours: Aug 11, 2026, 7:56 PM EDT
Find any stock by ticker or company name

NCM – Real Time Price. Currency in USD
2.32
-0.03 (-1.28%)
Market open: Aug 12, 2026, 12:30 PM EDT
2.18
-0.17 (-7.23%)
Previous after-hours: Aug 11, 2026, 7:56 PM EDT
Femasys Inc., a biomedical company, develops and commercializes therapeutic and diagnostic products for women’s reproductive health needs in the United States and internationally. The company offers FemaSeed, an intratubal insemination device; FemVue, a companion diagnostic for fallopian tube assessment through ultrasound; FemSperm, a sperm handling kit; FemChec, a confirmation test for tubal patency; FemCerv, an endocervical tissue sampler for cervical cancer diagnosis; and FemCath, a cornual balloon catheter for selective tube evaluation. It also provides FemBloc, a non-surgical female permanent birth control solution. The company offers its products to gynecological physicians, related healthcare professionals, and women’s healthcare provider organizations. Femasys Inc. was incorporated in 2004 and is headquartered in Suwanee, Georgia.
| Name | Position |
|---|---|
| Dr. James H. Liu M.D. | Chief Medical Officer |
| Mr. Dov Elefant | Chief Financial Officer |
| Mr. Jeremy Alexander Sipos | Chief Technology Officer |
| Mr. John Canning | Chief Operating Officer |
| Ms. Kathy Lee-Sepsick M.B.A. | Founder, President, CEO & Director |
| Date | Type | Document |
|---|---|---|
| 2026-08-11 | 8-K | ef20079916_8k.htm |
| 2026-06-24 | 8-K | ef20076788_8k.htm |
| 2026-06-05 | 8-K | ef20075587_8k.htm |
| 2026-06-04 | 8-K | ef20075450_8k.htm |
| 2026-05-13 | 8-K | ef20073379_8k.htm |
| 2026-05-08 | 8-K | ef20072749_8k.htm |
| 2026-05-08 | 10-Q | ef20070477_10-q.htm |
| 2026-04-30 | DEF 14A | ef20071760_def14a.htm |
| 2026-04-29 | 8-K | ef20071893_8k.htm |
| 2026-04-06 | DEF 14A | ef20069692_def14a.htm |